Latest Articles

Publication Date
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - BioSpace

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test BioSpace

Published: March 31, 2026, 4:17 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - The Joplin Globe

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test The Joplin Globe

Published: March 31, 2026, 1:02 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - joplinglobe.com

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test joplinglobe.com

Published: March 31, 2026, 1:02 p.m.
Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test - Business Wire

Ending the Diagnostic Delay: Feinstein Institutes’ ROSE Study Continues to Advance Critical Endometriosis Diagnostic Test Business Wire

Published: March 31, 2026, 1 p.m.
Endometrics Wins First Prize in NIH Endometriosis Diagnostics Challenge - Femtech Insider

Endometrics Wins First Prize in NIH Endometriosis Diagnostics Challenge Femtech Insider

Published: March 23, 2026, 12:42 p.m.
Endometriosis Blood Test: Improving Diagnostic Accuracy - OC Academy

Endometriosis Blood Test: Improving Diagnostic Accuracy OC Academy

Published: March 18, 2026, 1:07 p.m.
Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - Digital Journal

Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis Digital Journal

Published: March 18, 2026, 12:41 p.m.
Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - ACCESS Newswire

Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis ACCESS Newswire

Published: March 18, 2026, 10:13 a.m.
FinancialContent - Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - FinancialContent

FinancialContent - Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis FinancialContent

Published: March 18, 2026, 10 a.m.
Diamens Raises Funding to Develop Menstrual Blood-Based Endometriosis Diagnostic - Femtech Insider

Diamens Raises Funding to Develop Menstrual Blood-Based Endometriosis Diagnostic Femtech Insider

Published: March 17, 2026, 11:20 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!